Updates in the management of stable chronic obstructive pulmonary disease.

{"article_title":"Updates in the management of stable chronic obstructive pulmonary disease.","author":"Narsingam, Saiprasad, Bozarth, Andrew L., Abdeljalil, Asem","journal_title":"Postgraduate medicine","issn":"1941-9260","isbn":"","publication_date":"Nov2015","volume":"127","issue":"7","first_page":"758","page_count":"","accession_number":"EPTOC114328562","doi":"10.1080\/00325481.2015.1084212","publisher":"Taylor & Francis Ltd","doctype":"","subjects":"United States","interest_area":["Pulmonology"," Emergency Medicine"," ENT"],"abstract":"Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease state characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory process. It is increasingly recognized as a major public health problem, affecting more than 20 million adults in the US. It is also recognized as a leading cause of hospitalizations and is the fourth leading cause of death in the US. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) operates to promote evidence-based management of COPD, increase awareness and encourage research. In 2011, GOLD published a consensus report detailing evidence-based management strategies for COPD, which were last updated in 2015. In recent years, newer strategies and a growing number of new pharmacologic agents to treat symptoms of COPD have also been introduced and show promise in improving the management of COPD. We aim to provide an evidence-based review of the available and upcoming pharmacologic and non-pharmacologic treatment options for stable COPD, with continued emphasis on evidence-based management.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=EPTOC114328562&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Narsingam, Saiprasad, Bozarth, Andrew L., Abdeljalil, Asem","Journal_Info":"Publisher: Taylor & Francis Ltd ISSN: 0032-5481","Published_Date":"2015-11-01","Source":"Postgraduate medicine Nov2015; Vol. 127 (7).","Languages":"English","Subjects":"Obstructive lung disease treatment, Public health, Inflammation, Evidence-based medicine, Pharmacology","Title_Abbreviations":"Postgraduate medicine","Volume":"127"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"EPTOC114328562","RelevancyScore":"786","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"786.441101074219"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC114328562&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC114328562&authtype=shib&custid=ns346513&group=main&profile=eds"}